Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02383212
Title Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona United States Details
Western Regional Medical Center Goodyear Arizona United States Details
Mayo Clinic Phoenix Arizona United States Details
University of Arizona Cancer Center Tucson Arizona United States Details
City of Hope National Medical Center Duarte California United States Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Ronald Reagan UCLA Medical Center Los Angeles California United States Details
Stanford University Stanford California United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado United States Details
Norwalk Hospital Norwalk Connecticut United States Details
Georgetown University Medical Center Washington District of Columbia United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida United States Details
Winship Cancer Institute, Emory University Atlanta Georgia United States Details
University of Chicago Chicago Illinois United States Details
Indiana University Indianapolis Indiana United States Details
University of Kansas Cancer Center Fairway Kansas United States Details
Dana Farber Cancer Institute Boston Massachusetts United States Details
Barbara Ann Karmanos Cancer Center Detroit Michigan United States Details
Washington University School of Medicine Siteman Cancer Center Saint Louis Missouri United States Details
Nebraska Methodist Hospital Omaha Nebraska United States Details
Hackensack University Medical Center Hackensack New Jersey United States Details
Cancer Institute of New Jersey New Brunswick New Jersey United States Details
Columbia University Medical Center New York New York United States Details
Laura & Isaac Perlmutter Cancer Center New York New York United States Details
Mount Sinai Medical Center New York New York United States Details
Weill Cornell Medical College New York New York United States Details
Duke Cancer Institute Durham North Carolina United States Details
University Hospitals Case Medical Center Cleveland Ohio United States Details
Stephenson Cancer Center Oklahoma City Oklahoma United States Details
Providence Portland Medical Center Portland Oregon United States Details
Penn State Milton S Hershey Medical Center Hershey Pennsylvania United States Details
University of Pittsburgh Medical Center Shadyside Pittsburgh Pennsylvania 15232 United States Details
Miriam Hospital Providence Rhode Island United States Details
Sarah Cannon Research Institute Nashville Tennessee United States Details
Vanderbilt University Medical Center Nashville Tennessee United States Details
Mary Crowley Cancer Research Center - Medical City Dallas Texas United States Details
Baylor College of Medicine Houston Texas United States Details
The University of Texas MD Anderson Cancer Center Houston Texas United States Details
START South Texas Accelerated Research Therapeutics San Antonio Texas United States Details
Northwest Medical Specialties Tacoma Washington United States Details
Peter Maccallum Cancer Centre Melbourne Australia Details
Institut Catala d'Oncologia L'hospitalet L'Hospitalet de Llobregat Barcelona Spain Details
Hospital Universitario Vall d'Hebron Barcelona Spain Details
Fundacion Jimenez Diaz Madrid Spain Details
Hospital Universitario HM Sanchinarro-CIOCC Madrid Spain Details
Hospital Universitario Ramon y Cajal Madrid Spain Details
MD Anderson Cancer Center Madrid Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field